Australian Clinical Labs Limited

ASX:ACL Rapporto sulle azioni

Cap. di mercato: AU$515.3m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Australian Clinical Labs Gestione

Gestione criteri di controllo 4/4

Australian Clinical Labs' Il CEO è Melinda McGrath, nominato in Dec2020, e ha un mandato di 3.67 anni. la retribuzione annua totale è A$ 1.18M, composta da 74.2% di stipendio e 25.8% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 1.46% delle azioni della società, per un valore di A$ 7.51M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.1 anni e 3.3 anni.

Informazioni chiave

Melinda McGrath

Amministratore delegato

AU$1.2m

Compenso totale

Percentuale dello stipendio del CEO74.2%
Mandato del CEO3.7yrs
Proprietà del CEO1.5%
Durata media del management5.1yrs
Durata media del Consiglio di amministrazione3.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt

Jun 20
We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt

Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?

Feb 21
Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?

Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

Dec 08
Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Aug 14
Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Feb 25
Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

Dec 22
New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

Dec 21
The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

Sep 01
The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Melinda McGrath rispetto agli utili di Australian Clinical Labs?
DataCompenso totaleStipendioGuadagni aziendali
Dec 31 2023n/an/a

AU$15m

Sep 30 2023n/an/a

AU$26m

Jun 30 2023AU$1mAU$873k

AU$36m

Mar 31 2023n/an/a

AU$55m

Dec 31 2022n/an/a

AU$73m

Sep 30 2022n/an/a

AU$126m

Jun 30 2022AU$2mAU$873k

AU$178m

Mar 31 2022n/an/a

AU$156m

Dec 31 2021n/an/a

AU$134m

Sep 30 2021n/an/a

AU$97m

Jun 30 2021AU$2mAU$875k

AU$60m

Mar 31 2021n/an/a

AU$79m

Dec 31 2020n/an/a

AU$98m

Sep 30 2020n/an/a

AU$70m

Jun 30 2020AU$2mAU$852k

AU$41m

Compensazione vs Mercato: La retribuzione totale di Melinda ($USD 786.54K ) è circa la media per le aziende di dimensioni simili nel mercato Australian ($USD 838.87K ).

Compensazione vs guadagni: La retribuzione di Melinda è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Melinda McGrath

3.7yrs

Mandato

AU$1,175,644

Compensazione

Ms. Melinda McGrath is Chief Executive Officer and Executive Director at Australian Clinical Labs Limited since December 19, 2020. She served as Chief Executive Officer and Executive Director at Clinical L...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Melinda McGrath
CEO & Executive Director3.7yrsAU$1.18m1.46%
A$ 7.5m
Lana Hudson
Deputy Chief Financial Officerless than a yearNessun datoNessun dato
Anthony Friedli
Chief Operating Officer8.6yrsNessun dato0.38%
A$ 1.9m
Sean Jackson
Chief Information Officer9.6yrsNessun datoNessun dato
Joe Geran
National Marketing Directorno dataNessun datoNessun dato
Tony Landgren
National Medical Director & Chief Pathologist15.6yrsNessun dato0.42%
A$ 2.2m
Chris Brownlow
Chief Executive Officer of New South Wales & Australian Capital Territory13.6yrsNessun datoNessun dato
Shae Seymour
Chief Executive Officer of WA/SA/NT6.6yrsNessun datoNessun dato
Eleanor Padman
Company Secretary3.3yrsNessun datoNessun dato
Rob Izzard
Chief Executive Officer of ACL Commercial Pathology1.6yrsNessun datoNessun dato
Darren McKee
Chief Executive Officer of Victoria1.6yrsNessun datoNessun dato

5.1yrs

Durata media

Gestione esperta: Il team dirigenziale di ACL è esperto e expertise (durata media dell'incarico 5.1 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Melinda McGrath
CEO & Executive Director3.7yrsAU$1.18m1.46%
A$ 7.5m
Michael Alscher
Non-Executive Chairmanless than a yearAU$190.00k0.14%
A$ 720.9k
Christine Bartlett
Independent Non-Executive Directorless than a yearNessun dato0.010%
A$ 51.4k
Andrew Dutton
Independent Non-Executive Director3.3yrsAU$145.66k0.041%
A$ 210.5k
Nathanial Thomson
Non Executive Director3.7yrsAU$130.00kNessun dato
Leanne Rowe
Independent Non-Executive Director3.3yrsAU$140.64k0.0025%
A$ 12.8k
Mark Haberlin
Independent Non-Executive Director3.3yrsAU$145.66k0.024%
A$ 122.1k

3.3yrs

Durata media

64yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di ACL sono considerati esperti (durata media dell'incarico 3.3 anni).